Real-World U.S. Data Support Azithromycin Use After Unscheduled Cesarean Deliveries
Source Summary
Following a landmark clinical trial demonstrating azithromycin's benefits, use of the antibiotic as an adjunctive treatment increased among women undergoing unscheduled cesarean deliveries in the United States. Postpartum infection rates declined after this increased adoption of azithromycin in this clinical setting.
Why it matters
The data demonstrate that clinical trial findings on azithromycin's effectiveness translated into real-world adoption and measurable reductions in postpartum infections for women undergoing emergency cesarean delivery.
